semaglutide fda submission Approves for New Indication Involving Cardiovascular Disease FDA accepts filing application for

Understanding what to avoid helps you tolerate treatment better and stay consistent with your weight loss plan

Choose the Fixed Plan" to keep your Mounjaro at the same price discounted 19,980 every month

GLP-1 Patent Expiry: The Next Big Pharma Race Has Already Begun GLP-1 agonists like semaglutide, tirzepatide, and liraglutide have completely reshaped the global diabetes and obesity landscape

This article examines Midi Health's clinical model, evidence base, and how genetic testing and compounded options may provide additional personalization for GLP-1 therapy

States like New Jersey have had to issue statements clarifying their regulations on compounding medications.